<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6336248\results\search\funders\results.xml">
  <result pre="impact and vaccine development RezzaGiovanni1http://orcid.org/0000-0001-8016-8556WeaverScott C.2*[1], Department of Infectious Diseases," exact="Istituto Superiore di Sanità," post="Rome, Italy[2], Institute for Human Infections and Immunity and"/>
  <result pre="Human Infections and Immunity and Department of Microbiology and Immunology," exact="University of Texas Medical Branch," post="Galveston, Texas, United States of AmericaDiemertDavid JosephEditor[], George Washington"/>
  <result pre="Texas Medical Branch, Galveston, Texas, United States of AmericaDiemertDavid JosephEditor[]," exact="George Washington University" post="School of Medicine and Health Sciences, UNITED STATES I"/>
  <result pre="Galveston, Texas, United States of AmericaDiemertDavid JosephEditor[], George Washington University" exact="School of Medicine" post="and Health Sciences, UNITED STATES I have read the"/>
  <result pre="initiated) chains of CHIKV transmission have been identified. Data from" exact="World Health Organization" post="(http://www.who.int/emergencies/diseases/chikungunya/en/) and Pan American Health Organization (https://www.paho.org/hq/index.php?option=com_topics&amp;amp;view=article&amp;amp;id=343&amp;amp;Itemid=40931&amp;amp;lang=en). CHIKV, chikungunya"/>
  <result pre="(181/clone25) United States Army Medical Research Institute of Infectious Diseases," exact="University of Maryland" post="Live-attenuated CHIKV strain 1 Completed Phase 2 [32, 33]"/>
  <result pre="1 Completed Phase 2 [32, 33] VRC-CHKVLP059-00-VP (PXVX0317 CHIKV-VLP) US" exact="National Institutes of Health," post="PaxVax Virus-like particle assembled from CHIKV proteins expressed in"/>
  <result pre="structural proteins Not reported Recruiting for Phase 1 (NCT03325075) pMCE321" exact="University of Pennsylvania," post="Philadelphia Structural protein genes E3, E2, and E1 linked"/>
  <result pre="(immunogenicity and efficacy in mice, immunogenicity in NHPs) [58] CHIKV/IRES" exact="University of Texas Medical Branch," post="Takeda Pharmaceuticals Recombinant CHIKV with subgenomic promoter replaced by"/>
  <result pre="Late preclinical (immunogenicity and efficacy in mice, NHPs) [41–43] EILV/CHIKV" exact="University of Texas Medical Branch" post="Recombinant Eilat/chikungunya chimeric virus that is replication-defective in vertebrate"/>
  <result pre="burden of chikungunya in the Americas. New Haven EliScholar, USA:" exact="Yale University;" post="2016. 28EckelsKH, HarrisonVR, HetrickFM. Chikungunya virus vaccine prepared by"/>
 </snippets>
</snippetsTree>
